Tom Powles: Summary of clinical trials in advanced non-clear cell RCC GU24

Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter:

“Summary of clinical trials in advanced non-clear cell RCC GU24. The studies are small and pathology mixed ‘the moons of Jupiter’. The focus on PD1 and VEGF was not driven by the biology. Large randomised trials such as SAMETA exploring MET in selected papillary seems like progress.”

Source: Tom Powles/X